相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Disease-specific interactome alterations via epichaperomics: the case for Alzheimer's disease
Stephen D. Ginsberg et al.
FEBS JOURNAL (2022)
Discovery and In Vivo Proof of Concept of a Highly Potent DualInhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase forthe Treatment of Alzheimer's Disease
Sandra Codony et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Mitochondria as a promising target for developing novel agents for treating Alzheimer's disease
Elena F. Shevtsova et al.
MEDICINAL RESEARCH REVIEWS (2021)
From combinations to multitarget-directed ligands: A continuum in Alzheimer's disease polypharmacology
Claudia Albertini et al.
MEDICINAL RESEARCH REVIEWS (2021)
A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy
Kundlik Gadhave et al.
MEDICINAL RESEARCH REVIEWS (2021)
Alzheimer's Disease: Related Targets, Synthesis of Available Drugs, Bioactive Compounds Under Development and Promising Results Obtained from Multi-target Approaches
Natalia F. F. Pirolla et al.
CURRENT DRUG TARGETS (2021)
Chalcones Acting as Inhibitors of Cholinesterases, β-Secretase and β-Amyloid Aggregation and other Targets for Alzheimer's Disease: A Critical Review
Giorgio Antoniolli et al.
CURRENT MEDICINAL CHEMISTRY (2021)
From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease
Jazmin Alarcon-Esposito et al.
CURRENT NEUROPHARMACOLOGY (2021)
Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets
Md. Sahab Uddin et al.
MOLECULAR NEUROBIOLOGY (2021)
Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review
Daniela Malafaia et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Elisabet Viayna et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer's Disease Multitarget Drug Discovery?
Angela De Simone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Emerging targets in drug discovery against neurodegenerative diseases: Control of synapsis disfunction by the RhoA/ROCK pathway
Olmo Martin-Camara et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
2020 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer's Disease
Marta Campora et al.
PHARMACEUTICALS (2021)
Recent Multi-target Approaches on the Development of Anti- Alzheimer's Agents Integrating Metal Chelation Activity
Silvia Chaves et al.
CURRENT MEDICINAL CHEMISTRY (2021)
β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy
Aurelien Beato et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases
Andrea Bacci et al.
ANTIOXIDANTS (2021)
Aducanumab: European agency rejects Alzheimer's drug over efficacy and safety concerns
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2021)
Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents
Zhi Du et al.
ACCOUNTS OF CHEMICAL RESEARCH (2021)
Dual sEH/COX-2 Inhibition Using PTUPB-A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity
Wojciech K. Jankiewicz et al.
FRONTIERS IN PHARMACOLOGY (2021)
Promising tacrine/huperzine A-based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget
Shinghung Mak et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer's disease
Changjun Zhang et al.
BIOORGANIC CHEMISTRY (2021)
Multitarget therapeutic approaches for Alzheimer's and Parkinson's disease: an opportunity or an illusion?
Maria Joao Matos
FUTURE MEDICINAL CHEMISTRY (2021)
GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways
Stefania Demuro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist
Xiangqian Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease
Niels D. Prins et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer's disease
Kamil Borkowski et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Alzheimer's disease drug development pipeline: 2021
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)
Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments
Oscar M. Bautista-Aguilera et al.
CHEMICAL RECORD (2021)
Recent Advances in the Rational Drug Design Based on Multi-target Ligands
Ting Yang et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands
Aida Iraji et al.
BIOORGANIC CHEMISTRY (2020)
A Perspective on Multi-target Drugs for Alzheimer's Disease
Ondrej Benek et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Using sigma-ligands as part of a multi-receptor approach to target diseases of the brain
James Michael Brimson et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations
Samuele Maramai et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities
Daniel A. Rodrigues et al.
MEDICINAL RESEARCH REVIEWS (2020)
Phosphorylated tau interactome in the human Alzheimer's disease brain
Eleanor Drummond et al.
BRAIN (2020)
Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
Agnieszka Zagorska et al.
MOLECULES (2020)
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease
Christian Grinan-Ferre et al.
NEUROTHERAPEUTICS (2020)
Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization
Hamad Yadikar et al.
PLOS ONE (2020)
Merged Tacrine-Based, Multitarget-Directed Acetylcholinesterase Inhibitors 2015-Present: Synthesis and Biological Activity
Todd J. Eckroat et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease
Wenjun Chen et al.
JOURNAL OF NEUROSCIENCE (2020)
Memantine Derivatives as Multitarget Agents in Alzheimer's Disease
Giambattista Marotta et al.
MOLECULES (2020)
Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs
Mark J. Millan et al.
NEUROPHARMACOLOGY (2020)
Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains
Christian Haenig et al.
CELL REPORTS (2020)
Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer's Disease
Marcia Martins et al.
PHARMACEUTICALS (2020)
Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer
Amarjyoti Das Mahapatra et al.
MOLECULES (2020)
An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease
Anamitra Ghosh et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Alzheimer's disease drug development pipeline: 2020
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)
Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds
Ewgenij Proschak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity
Kerstin Hiesinger et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2019)
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Junting Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Multi-target design strategies for the improved treatment of Alzheimer's disease
Pengfei Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
Knut Biber et al.
FRONTIERS IN PHARMACOLOGY (2019)
Cognitive symptoms of Alzheimer's disease: clinical management and prevention
Elizabeth Joe et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
History and progress of hypotheses and clinical trials for Alzheimer's disease
Pei-Pei Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes
Md Abdul Hye Khan et al.
DIABETOLOGIA (2018)
Alzheimer's disease hypothesis and related therapies
Xiaoguang Du et al.
TRANSLATIONAL NEURODEGENERATION (2018)
Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation
Sonia Villapol
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Therapeutics of Neurotransmitters in Alzheimer's Disease
Ramesh Kandimalla et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis
Jurema Schmidt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Deficiency of Neuronal p38α MAPK Attenuates Amyloid Pathology in Alzheimer Disease Mouse and Cell Models through Facilitating Lysosomal Degradation of BACE1
Laura Schnoeder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease
Ester Aso et al.
FRONTIERS IN NEUROSCIENCE (2016)
Tau protein kinases: Involvement in Alzheimer's disease
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
Human Disease and Drug Pharmacology, Complex as Real Life
E. Viayna et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Activation of the CB2 receptor system reverses amyloid-induced memory deficiency
Jiang Wu et al.
NEUROBIOLOGY OF AGING (2013)
Dual-Target Virtual Screening by Pharmacophore Elucidation and Molecular Shape Filtering
Daniel Moser et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Interactome mapping suggests new mechanistic details underlying Alzheimer's disease
Montserrat Soler-Lopez et al.
GENOME RESEARCH (2011)
Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
The physicochemical challenges of designing multiple ligands
Richard Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Designed multiple ligands. An emerging drug discovery paradigm
R Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)